A detailed history of Howard Hughes Medical Institute transactions in Amgen Inc stock. As of the latest transaction made, Howard Hughes Medical Institute holds 116 shares of AMGN stock, worth $34,555. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116
Holding current value
$34,555
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$262.28 - $309.85 $30,424 - $35,942
116 New
116 $32,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Howard Hughes Medical Institute Portfolio

Follow Howard Hughes Medical Institute and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Hughes Medical Institute, based on Form 13F filings with the SEC.

News

Stay updated on Howard Hughes Medical Institute with notifications on news.